UMIN ID: C000000341
Registered date:31/03/2006
Randomised controlled trial of multiple drugs combined therapy for diffuse IgA nephropathy
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Refractory IgA nephropathy |
| Date of first enrollment | 2004/04/01 |
| Target sample size | 60 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Prednisolone and anti-thrombocyte and angiotensin II receptor blocker or angiotensin converting enzyme inhibitor inhibitor mizoribine and Prednisolone and anti thrombocyte and angiotensin II receptor blocker or angiotensin-converting enzyme |
Outcome(s)
| Primary Outcome | Changing percentage of Ccr and urinary protein. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 16years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | patients who's Ccr. Are Under 50ml/min or s-Cr. are over 2.0 mg/dl patients who have severe liver dysfunction pregnant or nursing women patients with a hypersensitivity to each thrapy drugs Judged inapproopriate for the physicians |
Related Information
| Primary Sponsor | Japanese Study Group of Multiple drug therapy for IgAN |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | The kidney Foundation, Japan |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Tetsuya Mitarai |
| Address | 1981-Kamoda, Kawagoeshi, Saitama Japan |
| Telephone | 049-228-3604 |
| mitarai@saitama-med.ac.jp | |
| Affiliation | Japanese Study Group of Multiple drug therapy for IgAN Department of Nephrology and Hypertension, Saitama Medical Center, Saitama Medical School |
| scientific contact | |
| Name | Tetsuya Mitarai |
| Address | 1981- Kamoda, Kawagoeshi, SAITAMA 350-8550, JAPAN Japan |
| Telephone | 049-228-3604 |
| mitarai@saitama-med.ac.jp | |
| Affiliation | Saitama Medical Center, Saitama Medical School Department of Nephrology and Hypertension |